Yvonne Lin- Liu MD, MS

Dr. Yvonne G. Lin is a board-certified gynecologic oncologist with particular expertise in novel cancer therapies for gynecologic malignancies. She was a physician-scientist at the University of Southern California (USC) studying the role of metabolic and protein stress on cancer development and progression. Her clinical research studied new ways to harness and re-direct the body’s immune system as part of cancer treatment. She has received grants from the NCI and several foundations towards these efforts, before transitioning into a full-time role at Genentech-Roche to advance the development of new targeted cancer therapies for women with cancer.

Dr. Lin graduated from the Massachusetts Institute of Technology, then completed graduate studies at the Harvard School of Public Health before embarking on a Fulbright Fellowship to Taiwan. She returned to medical school, earning her medical degree from the University of California, Irvine, before returning to Boston to complete her residency in obstetrics-gynecology at the Beth Israel Deaconess Medical Center. Subsequently, Dr. Lin completed her gynecologic oncology fellowship at the University of Texas, M.D. Anderson Cancer Center were she was a T32 grant recipient. Her research has been presented at multiple meetings and published in prominent journals, such as Cancer, NEJM, JNCI, Clinical Cancer Research, and Oncogene. Dr. Lin is currently an assistant medical director at Genentech-Roche.